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Abstract
Appropriate measures of infection prevention and management are integral to optimal clinical practice and
standards of care. Among surgeons, these measures are often over-looked. However, surgeons are at the forefront
in preventing and managing infections. Surgeons are responsible for many of the processes of healthcare that
impact the risk for surgical site infections and play a key role in their prevention. Surgeons are also at the forefront
in managing patients with infections, who often need prompt source control and appropriate antibiotic therapy,
and are directly responsible for their outcome. In this context, the direct leadership of surgeons in infection
prevention and management is of utmost importance. In order to disseminate worldwide this message, the
editorial has been translated into 9 different languages (Arabic, Chinese, French, German, Italian, Portuguese,
Spanish, Russian, and Turkish).
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Background
The challenge
In a book, by the surgeon Sherwin B. Nuland, on the
history of Ignaz Philipp Semmelweis [1], the author re-
fers to puerperal fever as the “doctors’ plague,” because
these same doctors and medical students, who treated
the patients, spread the infection by their hands. During
the mid-nineteenth century, a disease characterized by
pain, general malaise, and high fever, known as “puer-
peral fever,” literally decimated the new mothers
hospitalized in the Vienna University hospital where Dr.
Semmelweis worked. Without knowing the existence of
bacteria (discovered by Louis Pasteur only in the second
half of nineteenth century), he understood that the mor-
tality rate could be reduced by doctors’ hand washing
with chlorinated lime solution before every examination.
Semmelweis’s observations conflicted with the estab-
lished scientific and medical opinions of the time, and
he was treated as an outcast. He is now known as “father
of infection control.” Beginning with the discovery of
penicillin by Alexander Fleming in the late 1920s, antibi-
otics have revolutionized the field of medicine [2].
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They have saved millions of lives each year and have even
been used prophylactically for the prevention of infectious
diseases. However, bacteria have developed resistance to anti-
biotics, causing infections that are more serious because they
are increasingly resistant to antibiotics. Using this perspec-
tive, current infections may be defined as the new “doctors’
plague,” because the same doctors through inappropriate use
of antibiotics and inadequate infection prevention are con-
tributing to the development and spread of antimicrobial re-
sistance (AMR).
Surgeons in their clinical practice are at the forefront
in preventing and managing infections. However, among
surgeons, appropriate measures of infection prevention
are often disregarded. The lack of awareness of these
measures has marginalized surgeons from this fight. In
many hospitals around the world, surgeons are not in-
volved in the antimicrobial stewardship programs des-
pite the fact that they are frequent prescribers of
antibiotics both for prophylaxis and therapy. Further-
more, surgeons are often not involved in infection pre-
vention teams, yet they are primarily responsible for
preventing hospital-acquired infections, particularly sur-
gical site infections. We submit that if surgeons around
the world would participate in this global fight, they will
be pivotal leaders in addressing this challenge.
In order to disseminate worldwide this message, the
editorial has been translated into 9 different languages:
Arabic, Chinese, French, German, Italian, Portuguese,
Spanish, Russian, and Turkish (Additional files 1, 2, 3, 4,
5, 6, 7, 8 and 9).
Main text
The global threat of AMR
Improving patient safety in today’s hospitals worldwide
requires a systematic approach to combat AMR and to
prevent and treat infections appropriately. The two con-
cepts go hand-in-hand [3]. AMR has emerged as one of
the major public health problems of the twenty-first cen-
tury. This has resulted in a public health crisis of inter-
national proportions, which threatens the practice of
modern medicine, animal health, and food security [4].
The threat of AMR represents arguably the greatest patient
safety challenge of our time. It has been widely reported that
the world is on the cusp of a “post-antibiotic era,” with the
growth in multidrug resistant bacteria raising the prospect
that modern medicine will be increasingly unable to treat
what are currently considered to be routine infections. AMR
is a natural phenomenon that occurs as bacteria evolve.
However, human activities have accelerated the pace at
which bacteria develop and propagate resistance.
Global initiative to fight AMR
Addressing the rising threat of AMR requires a holistic
and multidisciplinary approach—referred to as One
Health—because antibiotics used to treat various animal
infectious diseases may be very similar to those used to
treat humans [5].
Resistant bacteria arising in humans, animals, or the
environment may spread from one to the other and
from one country to another. AMR is not limited to geo-
graphic or zoologic borders [3]. Healthcare workers
must play a central role in preventing the emergence
and spread of AMR. Hospitalized patients often have
multiple risk factors for acquisition of AMR. Acute care
facilities are incubators for the development of AMR [6].
The intensity of care and the highly susceptible patient
populations create an environment which facilitates both
the emergence and transmission of resistant organisms.
Appropriate use of antibiotics
Appropriate use of antibiotics is an integral part of opti-
mal clinical practice. Antibiotics can be lifesaving when
treating patients with bacterial infections. But they are
often used inappropriately, specifically when unnecessary
or when administered for excessive duration or without
consideration of pharmacokinetic principles [7, 8]. The
misuse of antibiotics is widely accepted as a major driver
of some emerging infections (such as C. difficile), the se-
lection of resistant pathogens in individual patients, and
for the continued development of AMR globally [3].
Prevention of surgical site infections (SSIs)
In 2017, the Global Alliance for Infections in Surgery
shared with over 230 experts from 83 different countries
a global declaration on appropriate use of antimicrobial
agents in hospitals worldwide [3]. Within this declar-
ation, the authors highlighted the contribution of anti-
biotic exposure, misuse, and overuse to the development
of AMR and outlined the fundamental principles of ap-
propriate antibiotic prophylaxis and therapy across the
surgical pathway. Efforts to prevent hospital-acquired in-
fections (HAIs) were not specifically highlighted in their
declaration, but they are of significant importance in
limiting antibiotic exposure.
Prevention is better than cure, and every infection pre-
vented is one that needs no treatment. Prevention of
infection can be cost effective and implemented every-
where, even where resources are limited. The surgical
community continues to be cavalier in its approach to
infection prevention and control. Patients with medical
devices (central lines, urinary catheters, ventilators) or
who undergo surgical procedures are at risk of acquiring
HAIs. HAIs result in significant morbidity and mortality,
prolong the duration of hospital stay, and necessitate
additional diagnostic and therapeutic interventions. Sur-
geons continue to be obtuse to this reality with limited
response to requests for intervention. Surgical site infec-
tions (SSIs) are the most common HAIs among surgical
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patients. In recent years, many comprehensive sets of
guidelines for the prevention of surgical site infections
have been published [9–11]. Despite clear evidences and
guidelines to direct SSI prevention strategies, compliance
is universally poor [12].
Source control in surgical infections
When surgical infection occurs, the source of infection
should be recognized and controlled. Whether related to
a catheter, abscess or device all measures should be
undertaken to eliminate the source and reduce the bac-
terial inoculum [13, 14]. Appropriate source control is of
outmost importance in the management of surgical in-
fections. Intra-abdominal infections along with soft tis-
sues infections are the sites where source control is
impactful. In these settings, an appropriate source con-
trol can improve patients’ outcome and reduce pro-
longed courses of antibiotic therapy. As a general
principle, every verified source of infection should be
controlled as soon as possible. The level of urgency of
treatment is determined by the affected organ(s), the
relative speed at which clinical symptoms progress, and
the underlying physiological stability of the patient.
Obstacles to overcome for surgeons
Leading international organizations acknowledge that
collaboration is essential in providing care that is appro-
priate to meet the needs of patients, optimize individual
health outcomes, and overall health care delivery [15]. A
collaborative approach allows each member of the team
to contribute expertise and to be responsible for their
respective contributions to patient care. To be a cham-
pion in preventing and managing infections across the
surgical spectrum involves the creation of a culture of
collaboration in which infection prevention and control,
antimicrobial stewardship, and optimal surgical ap-
proaches are all taken into consideration and respected
by all members of the team.
Surgeons are at the forefront in preventing infections.
Surgeons are responsible for many of the processes of
healthcare that impact the risk for SSIs and play an im-
portant role in their prevention. Surgeons are also at the
forefront in managing patients with infections, who
often need prompt source control and adequate anti-
biotic therapy being directly responsible for their out-
come. In this context, their leadership in the
multidisciplinary efforts to improve the quality of the
surgical patient is critical. To be leaders, surgeons
should be aware that the appropriate prevention and
management of infections across the surgical spectrum
is an integral part of best practice.
In hospitals, cultural, contextual, and behavioral deter-
minants influence clinical practice. Improving behavior
in infection prevention and management remains a
challenge. A range of factors such as diagnostic uncer-
tainty, fear of clinical failure, time pressure, or
organizational contexts can complicate the surgeons’ ap-
proach towards infections. However, due to cognitive
dissonance (recognizing that an action is necessary but
not implementing it), changing behavior is challenging.
There are generally three primary levels that may influ-
ence surgeons’ behavior modification on infection pre-
vention and management. These include the following:
1) Intrapersonal level.
2) Interpersonal level.
3) Institutional or organizational level.
On an individual level, surgeons should have the ne-
cessary knowledge, skills, and abilities to implement ef-
fective infection prevention and management practices.
Improving their knowledge may influence their percep-
tions and motivate them to change behavior. Education
and training represent an important component for ac-
curate implementation of recommendations. Education
of surgeons in prevention and management of infections
should begin at the undergraduate level and be consoli-
dated with further training throughout the postgraduate
years. Hospitals are responsible for educating clinical
staff. Education techniques, such as educational work-
shops, should be implemented in each hospital world-
wide according to their own resources.
Surgeons as leaders and champions in an interdisciplinary
group to fight AMR
However, increasing knowledge alone may not be suffi-
cient and may not be effective in changing practice, un-
less education is interactive and continuous, and
includes discussions on evidence, local consensus, feed-
back on performance (by peers), making personal and
group learning plans, etc. Identifying a local opinion
leader to serve as a champion is important because the
“champion” may integrate best clinical practices and
drive their colleagues into changing behaviors. Surgeons
with satisfactory knowledge in surgical infections may
provide feedback to the prescribers and implement
change within their own sphere of influence interacting
directly with both the antimicrobial stewardship group
and the infection control group. Excluding surgeons
have increased the barriers to applying best practices.
Finally, organizational obstacles may influence infec-
tion prevention and management. Many different hos-
pital disciplines are typically involved in infection
prevention and management, making collaboration, co-
ordination, communication, teamwork, and efficient care
an essential component of success. There is now a sub-
stantial body of evidence that effective teamwork in
health care contributes to improved outcomes. Using
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this approach reinforces, the concept that each discipline
brings particular expertise and is responsible for their re-
spective contributions to patient care. Across the
surgical spectrum, it means creating a culture of collabor-
ation in which infection prevention and control, anti-
microbial stewardship, and correct surgical approach are
all of utmost importance and properly coordinated. In this
context, the direct leadership of surgeons, who are directly
responsible for their patients, is of utmost importance.
Conclusions
If surgeons around the world participate in this global
fight, they will be pivotal leaders in addressing this chal-
lenge. Otherwise, they will be contributors to the worst
crisis that the world health is facing.
Hey surgeons! It is your call! It is your time to partici-
pate and your time to lead. Now is the time to act!
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